SKI Market

Indian Indices

Sensex

82,626.51 -619.67
( -0.74%)

Global Indices

Nasdaq

49,380.33 -83.12
(-0.17%)

Dow Jones

6,961.01 -4.46
(-0.06%)

Hang Seng

53,052.63 -530.94
(-0.99%)

Nikkei 225

10,200.95 -34.34
(-0.34%)

Forex

USD-INR

90.54 0.22
(0.24%)

EUR-INR

105.01 0.03
(0.03%)

GBP-INR

121.08 -0.01
(-0.01%)

JPY-INR

0.57 0.00
(0.52%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

35.34

33582.07

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.05

Back

Board of Amrutanjan Health Care recommends First Interim Dividend

Nov 10,2025

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.1 per share (i.e.100%), subject to the approval of the shareholders.

82,626.51 -619.67 ( -0.74%)

49,380.33 -83.12 (-0.17%)

6,961.01 -4.46 (-0.06%)

53,052.63 -530.94 (-0.99%)

10,200.95 -34.34 (-0.34%)

90.54 0.22 (0.24%)

105.01 0.03 (0.03%)

121.08 -0.01 (-0.01%)

0.57 0.00 (0.52%)